Literature DB >> 15880941

Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors.

Soo Joon Sohn1.   

Abstract

CONCLUSION: SP upregulates osteoclastogenesis by activating NF-kappaB in osteoclast precursors.
OBJECTIVE: Osteoclastic bone resorption is a common finding of otitis media with or without cholesteatoma. Factors upregulating osteoclastogenesis are implicated in bone resorption. The aim of this study was to investigate the effect of substance P (SP) on mouse osteoclastogenesis in vitro.
MATERIAL AND METHODS: The SP dose response was analyzed in a mouse osteoclast culture induced by macrophage colony-stimulating factor and receptor activator for nuclear factor kappa B (NF-kappaB) ligand. Western blot analysis was performed to elucidate the subcellular target of SP in osteoclastogenesis.
RESULTS: Treatment with SP significantly increased osteoclastogenesis compared to control. SP activated nuclear translocation of NF-kappaB, which is an essential event in osteoclastogenesis in osteoclast precursors (bone marrow macrophages).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880941     DOI: 10.1080/00016480410017710

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  14 in total

1.  Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.

Authors:  Liping Wang; Xiaoyou Shi; Rong Zhao; Bernard P Halloran; David J Clark; Christopher R Jacobs; Wade S Kingery
Journal:  Bone       Date:  2009-12-02       Impact factor: 4.398

2.  Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.

Authors:  Liping Wang; Rong Zhao; Xiaoyou Shi; Tzuping Wei; Bernard P Halloran; David J Clark; Christopher R Jacobs; Wade S Kingery
Journal:  Bone       Date:  2009-04-18       Impact factor: 4.398

Review 3.  No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing.

Authors:  Seungyup Sun; Nicklaus H Diggins; Zachary J Gunderson; Jill C Fehrenbacher; Fletcher A White; Melissa A Kacena
Journal:  Bone       Date:  2019-11-09       Impact factor: 4.398

4.  Mice lacking substance P have normal bone modeling but diminished bone formation, increased resorption, and accelerated osteopenia with aging.

Authors:  Liping Wang; Saiyun Hou; Ilya Sabsovich; Tian-Zhi Guo; Tzuping Wei; Wade S Kingery
Journal:  Bone       Date:  2020-12-15       Impact factor: 4.398

Review 5.  Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology.

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

6.  Innervation is higher above Bone Remodeling Surfaces and in Cortical Pores in Human Bone: Lessons from patients with primary hyperparathyroidism.

Authors:  Manasi Sayilekshmy; Rie Bager Hansen; Jean-Marie Delaissé; Lars Rolighed; Thomas Levin Andersen; Anne-Marie Heegaard
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

7.  Akt-mediated anti-apoptotic effects of substance P in Anti-Fas-induced apoptosis of human tenocytes.

Authors:  Ludvig J Backman; Patrik Danielson
Journal:  J Cell Mol Med       Date:  2013-04-11       Impact factor: 5.310

8.  Substance P activates the Wnt signal transduction pathway and enhances the differentiation of mouse preosteoblastic MC3T3-E1 cells.

Authors:  Gang Mei; Zhenlv Zou; Su Fu; Liheng Xia; Jian Zhou; Yongtao Zhang; Yonghua Tuo; Zhao Wang; Dan Jin
Journal:  Int J Mol Sci       Date:  2014-04-11       Impact factor: 5.923

Review 9.  Biomarkers in orthodontic tooth movement.

Authors:  A Anand Kumar; K Saravanan; K Kohila; S Sathesh Kumar
Journal:  J Pharm Bioallied Sci       Date:  2015-08

Review 10.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.